 CAMBRIDGE, Mass., Jan. 03, 2023 GLOBE NEWSWIRE -- Prime Medicine, Inc. Nasdaq: PRME, a biotechnology company committed to delivering a new class of differentiated one-time curative genetic therapies, today announced that Keith Gottesdiener, M.D., President and Chief Executive Officer of Prime Medicine, will present a corporate overview at the 41st Annual J.P. Morgan Healthcare Conference on Monday, January 9, 2023 at 8:15 a.m. PT 11:15 a.m. ET in San Francisco, CA. 